文献速递儿童感染儿童心血管与肾脏儿童神经与发育行为

儿童多系统炎症综合征在COVID-19后长达4.5年的长期结局

Long-Term Outcomes of Multisystem Inflammatory Syndrome in Children up to 4.5 Years After COVID-19.
PubMed 文献 · Pediatrics · 2026-01-01

MIS-C组心血管、高血压、胃肠、呼吸和神经疾病风险显著升高,且原有高血压可预测多种结局。结论提示MIS-C可致多系统长期疾病负担,需结构化长期随访。

要点

  • MIS-C患儿心血管疾病风险显著升高(aHR=13.88)。
  • MIS-C组呼吸系统疾病持续风险达35.2%。
  • 建议常规血压监测及神经、心血管、肾脏监测。

核心结论

  • MIS-C与急性COVID-19后持续数年的广泛多系统疾病相关,挑战了既往认为该病为一过性的报告。

主要发现

  • 与无MIS-C者相比,MIS-C患者心血管疾病风险显著升高(aHR=13.88 [4.69-41.07],P < .001)。
  • MIS-C患者高血压风险显著升高(aHR=8.86 [4.12-19.06],P < .001)。
  • MIS-C患者胃肠道疾病风险显著升高(aHR=9.48 [2.66-33.71],P < .001)。
  • MIS-C患者呼吸系统疾病风险显著升高(aHR=3.46 [2.21-5.42],P < .001)。
  • MIS-C患者神经系统疾病风险显著升高(aHR=2.02 [1.22-3.34],P = .007)。

关键数值与推荐

  • 原有高血压(MIS-C组9.25% vs 对照组6.94%)显著预测心血管、神经、呼吸和胃肠道结局。
  • 年龄每增加1岁与休克风险增加相关(aHR=1.06 [1.02-1.11])及慢性肾脏病风险增加相关(aHR=1.06 [1.01-1.12])。
  • 原有糖尿病(MIS-C组1.73%)与慢性肾脏病风险增加49倍相关。
  • Kaplan-Meier分析显示MIS-C组所有结局的持续风险均更高,范围从慢性肾脏病的6.8%到呼吸系统疾病的35.2%。
  • 采用不同MIS-C定义的敏感性分析证实了主要发现。

临床怎么用

  • 建议对MIS-C患者进行结构化长期随访,包括常规血压监测、神经和心理筛查、心血管和肾脏监测,并协调多学科护理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The risk of persistent multisystem dysfunction following multisystem inflammatory syndrome in children (MIS-C), a severe postviral complication of COVID-19, remains unknown. METHODS: We investigated long-term outcomes in patients younger than 21 years with MIS-C (n = 173) vs without MIS-C (n = 14 190) up to 4.5 years after COVID-19 in the Montefiore Health System (March 2020 to August 2024). MIS-C status was based on International Classification of Diseases, Tenth Revision codes and Centers for Disease Control and Prevention and World Health Organization criteria. 1:2 propensity score matching and Cox proportional hazards regression with multivariable adjustment were performed. RESULTS: Compared with patients without, patients with MIS-C showed markedly higher risk of cardiovascular disorders (adjusted hazard ratio [aHR] = 13.88 [4.69-41.07], P < .001), hypertension (aHR = 8.86 [4.12-19.06], P < .001), gastrointestinal disorders (aHR = 9.48 [2.66-33.71], P < .001), respiratory disorders (aHR = 3.46 [2.21-5.42], P < .001), and neurological disorders (aHR = 2.02 [1.22-3.34], P = .007). Preexisting hypertension (9.25% of patients with MIS-C vs 6.94% of controls) significantly predicted cardiovascular, neurological, respiratory, and gastrointestinal outcomes. Each 1-year increase in age was associated with increased risk of shock (aHR = 1.06 [1.02-1.11]) and chronic kidney disease (CKD) (aHR = 1.06 [1.01-1.12]). Preexisting diabetes (1.73% of patients with MIS-C) was associated with a 49-fold increased risk of CKD. Kaplan-Meier analysis showed higher persistent risk in the MIS-C group across all outcomes, ranging from 6.8% for CKD to 35.2% for respiratory disorders. Sensitivity analysis using different definitions of MIS-C corroborated our main findings. CONCLUSIONS: MIS-C is associated with broad multisystem morbidity persisting years after acute COVID-19, challenging earlier reports of transient illness. Structured long-term follow-up, including routine blood pressure monitoring, neurological and mental-health screening, and cardiovascular and renal surveillance, with coordinated multidisciplinary care is warranted.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Mehrotra-Varma S, Nguyen HQ, Henry S, et al. Long-Term Outcomes of Multisystem Inflammatory Syndrome in Children up to 4.5 Years After COVID-19. Pediatrics. 2026. PMID: 42264467. doi:10.1542/peds.2025-075578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。